ADAM23 depletion leads to 140% increase in cerebral Aβ-amyloidosis and up to 190% increase in cytoplasmic NICD compared with ADAM23hi astrocytoma cells. This evidence concerns the gene ADAM23 and astrocytoma (excluding glioblastoma).